Key Takeaways
- Q3 generated 122 new IPO filings, topping Q2’s 111 and bringing the YTD total to a resilient 356 filings
- Only 76 (62%) of Q3 filings actually priced and set offering dates, the lowest level since Q4 2025
- Oura, Bamboo Insurance Services, and Amaero brought quarterly postponements to 3, tying a record high in our data going back to 2016
- 5 companies officially pulled their filings in Q3, signaling that smaller, highly sensitive issuers are opting to wait out macro chop
A few weeks ago , we examined how Wall Street's primary issuance desk was on pace for its strongest showing since the 2021 boom. Top-of-funnel registration activity was booming, and market participants were eagerly anticipating a grand autumn debut for mega-cap tech leaders. But as the books closed on Q3, while it was still a robust quarter for filings, that didn’t always result in offerings, and a couple of recent announcements noticeably changed the vibes.
The turning point was punctuated this week by two major strategic pauses. First, health-tech company Oura officially postponed its IPO, citing volatile "market conditions."1 Shortly after, OpenAI confirmed a delay to its own much-anticipated listing, pointing to internal safety evaluations and corporate governance readiness.2 The question now becomes whether these stalls are isolated events or if they foreshadow a broader tightening across the dealmaking landscape.
See more: From Open Models to Closed Platforms: The Next Generation of AI-Backed RegTech Is Here
By the Numbers - S-1 Filings Are Still Piling Up
If you only look at filings activity, the 2026 primary market recovery looks uninterrupted. According to our IPO data, licensed from IPOScoop, 122 new IPOs were filed in Q3, representing a solid uptick from Q2’s 111 and keeping pace right alongside Q1’s 123 peak for the year.
Through the first three quarters, companies have shown no hesitation in getting their initial paperwork in order. The desire to tap public equity markets remains exceptionally high across technology, industrial, and healthcare sectors alike.
The Conversion Bottleneck - Offerings Take a Hit
The real story of Q3, however, lies in the gap between filing an IPO and pricing one.
Out of the 122 new Q3 filings, only 76 went on to secure an offering date and price. That represents a 62% conversion rate, a steep slide from the previous quarter, where nearly all registered filings crossed the finish line, and a notable drop from Q1’s 82% ratio. In fact, Q3’s 62% offering-to-filing ratio marks the lowest conversion rate our dataset has seen since Q4 2025 (61%).
Postponements Match Record Highs
This growing hesitation is showing up clearly in deal mechanics. In Q3, 3 companies officially postponed their listings—Oura, Bamboo Insurance Services, and Amaero. That ties Q2 2018 for the highest quarterly postponement total in our records dating back to 2016.
At the same time, capitulation numbers saw a mild uptick. 5 companies formally withdrew their IPO applications in Q3: Holtec Nuclear Corp, Aspargo Labs, Living Homeopathy, Otsaw Limited, Gebe Environmental Technology.
While overall withdrawals remain far below the wave seen during the 2022 rate shock, the combination of record postponements and dropping conversion rates demonstrates that management teams and syndicate lead underwriters are no longer willing to force deals into market turbulence and possibly in wait-and-see mode.
The Bottom Line
The takeaway from Q3 isn't that the IPO recovery is dead, it's that it has entered a far more tactical phase. The appetite to register is undeniably present, but the window to price comfortably has narrowed. For big names like OpenAI and Oura, taking extra time to clear safety, governance, or market noise is a luxury of strength, not desperation. For smaller growth plays and speculative names, however, the elevated bar for pricing means waiting out the macro chop until Q4 or early 2027 brings clearer skies.
As we head into the final quarter of the year, watch the pricing spreads on upcoming mid-cap debuts carefully: they will tell us whether the Q3 friction was a temporary breather or the start of a broader standoff.
1 “Oura becomes latest US IPO hopeful to delay listing as market jitters deepen,” Reuters, Manya Saini, September 29, 2026,” https://www.reuters.com
2 “Sam Altman says OpenAI will delay its IPO until it overcomes safety concerns,” Financial Times, September 29, 2026, https://www.ft.com
Copyright © 2026 Wall Street Horizon, Inc. All rights reserved. Do not copy, distribute, sell or modify this document without Wall Street Horizon's prior written consent. This information is provided for information purposes only. Neither TMX Group Limited nor any of its affiliated companies guarantees the completeness of the information contained in this publication, and we are not responsible for any errors or omissions in or your use of, or reliance on, the information. This publication is not intended to provide legal, accounting, tax, investment, financial or other advice and should not be relied upon for such advice. The information provided is not an invitation to purchase securities, including any listed on Toronto Stock Exchange and/or TSX Venture Exchange. TMX Group and its affiliated companies do not endorse or recommend any securities referenced in this publication. This publication shall not constitute an offer to sell or the solicitation of an offer to buy, nor may there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. TMX, the TMX design, TMX Group, Toronto Stock Exchange, TSX, and TSX Venture Exchange are the trademarks of TSX Inc. and are used under license. Wall Street Horizon is the trademark of Wall Street Horizon, Inc. All other trademarks used in this publication are the property of their respective owners.
A message from Advisor Perspectives and VettaFi: Discover something new! Click here to register for our upcoming webcasts.
© Wall Street Horizon
More Mutual Funds Topics >
